FT. LAUDERDALE, FL--(Marketwire - May 19, 2008) - OmniComm Systems, Inc. (OTCBB: OMCM), a leader in integrated electronic data capture (EDC) solutions for clinical trials, today announced that the company has entered into a 5-year, multi-million dollar enterprise agreement with a major west coast biotechnology company. The agreement allows the biotech company to take full advantage of OmniComm’s First in Functionality™, EDC solution, TrialMaster™ for up to 10 concurrent trials per year. The biotech company will strategically utilize OmniComm’s EDC application to assist in managing their global clinical trials and clinical related data. The enterprise deal includes complete licensing, services and technical support for these 10 concurrent studies. The agreement also provides for an option to exceed 10 concurrent studies per year for a predetermined ‘per study’ price.
